Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,938 | -3,739 | -16,702 | -15,601 | -12,830 |
| Depreciation Amortization | 683 | 348 | 1,351 | 1,172 | 802 |
| Other Working Capital | -1,175 | 586 | -480 | 342 | 204 |
| Other Operating Activity | 144 | 346 | 5,204 | 6,655 | 6,412 |
| Operating Cash Flow | $-8,286 | $-2,459 | $-10,627 | $-7,432 | $-5,412 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -268 | -142 | -810 | -275 | -264 |
| Net Acquisitions | 3,008 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -3,392 | -3,392 | -3,392 |
| Sale Of Investment | N/A | N/A | 13,016 | 13,016 | 13,016 |
| Investing Cash Flow | $2,740 | $-142 | $8,814 | $9,349 | $9,360 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,975 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,000 | -1,000 | 0 | 0 | 0 |
| Financing Cash Flow | $8,975 | $-1,000 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 10,463 | 10,463 | 12,276 | 12,276 | 12,276 |
| End Cash Position | 13,892 | 6,862 | 10,463 | 14,193 | 16,224 |
| Net Cash Flow | $3,429 | $-3,601 | $-1,813 | $1,917 | $3,948 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,286 | -2,459 | -10,627 | -7,432 | -5,412 |
| Capital Expenditure | -268 | -142 | -875 | -484 | -329 |
| Free Cash Flow | -8,554 | -2,601 | -11,502 | -7,916 | -5,741 |